PB1950 GENERIC IMATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA‐ CLINICAL EXPERIENCE OVER A SIX YEAR PERIOD
Chrystalla Prokopiou(Limassol General Hospital), Paul Costeas(Deakin University), E. Giannou(Archbishop Makarios III Hospital), A. Frangoulides(Limassol General Hospital), Laura Koumas, Nikolaos Neokleous(Limassol General Hospital), P. Papadopoulos(Archbishop Makarios III Hospital), M. Lerni(Archbishop Makarios III Hospital), O. Seimeni(Limassol General Hospital), S. Koumas(Limassol General Hospital)
Cited by 0
Related Papers
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family
|Journal of Bacteriology|1992|586
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
|Leukemia|2015|258
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity
|Theranostics|2020|200